Hospice Of Eastern Idaho Medicare Approved Location: 1810 Moran Street, Idaho Falls, Idaho 83401 Phone: (208) 529-0342 |
Aspen Hospice Medicare Approved Location: 3470 Washington Parkway, Suite B, Idaho Falls, Idaho 83404 Phone: (208) 529-0800 |
Alliance Hospice Of Idaho Medicare Approved Location: 1270 South Woodruff, Idaho Falls, Idaho 83404 Phone: (208) 733-2234 |
Hands Of Hope Hospice Medicare Approved Location: 1379 East 17th Street, Idaho Falls, Idaho 83401 Phone: (208) 523-7441 |
Teton Hospice Medicare Approved Location: 2470 Jafer Court, Idaho Falls, Idaho 83404 Phone: (208) 529-3636 |
Avalon Hospice Medicare Approved Location: 3767 Professional Way, Idaho Falls, Idaho 83402 Phone: (208) 419-0896 |
News Archive
Men suffering from psychiatric problems when diagnosed with cancer are more likely to die from the disease, according to a new study published today in the British Journal of Cancer.
Considering the ever-expanding life span of Americans, quality and compliance in post-acute care services are becoming fundamental for post-acute care facilities, as well as patients who require assisted-living services or who are recovering from a major health condition. The facilities are increasingly adopting electronic health records and using mobile phones for e-prescribing, documentation and sharing of information with patients and family. In all this, it is imperative for them to keep their facility updated about the Feds newest compliance policies and traps.
Today's headlines highlight a White House plan to "get specific" on health reform, an analysis showing a nationwide jump in Medicaid enrollment and more on the firestorm surrounding health insurance premium increases.
Rettsyndrome.org announced their funding of two new research projects today. Jeannie T. Lee, MD, Ph.D. of Massachusetts General Hospital is awarded a two-year ANGEL Grant for $600,000 to focus on reactivating the silent X chromosome for Rett syndrome and Davut Pehlivan, MDof Baylor College of Medicine is awarded a two-year Mentored Clinical Fellowship for $250,000 to study MECP2 Duplication syndrome.
One of the greatest obstacles in the fight against cancer is the pace of the cancer research itself. Today, NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, launched an advertising campaign called "Dear Cancer Researchers" to unveil its industry-changing nCounter SPRINTâ„¢ Profiler.
› Verified 7 days ago